Tagala, Baby Girl -.

HRN: 27-15-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
MUPIROCIN 2%, 15G (TUBE)
05/29/2025
06/05/2025
TOPICAL
Pea-sized
BID
Skin Infection
Waiting Final Action 
05/31/2025
AMPICILLIN 250MG (VIAL)
05/31/2025
06/06/2025
IV
150mg
Q12
PSNB
Waiting Final Action 
05/31/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/31/2025
06/06/2025
IV
32mg
OD
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: